Dr. Dimanthi Pliatsika

Network

ORCID digital identifier

ORCID ID: 0000-0002-1970-8995

Projects

• Alzheimer's dementia / Team member / ongoing
• Evaluation of the potential of PROTACs / Deputy project leader / completed
• Platform for drug target identification / Deputy project leader / completed
• A topical anti-infective / Team member / completed
• Morbillivirus cell entry machinery: mechanisms, structures and antiviral drug discovery / Team member / completed

Publications

Articles in scientific journal, peer-reviewed

• Rimle, L. et al. (2025) 'Dissecting structural requirements of leucinostatin A derivatives for antiprotozoal activity and mammalian toxicity', Journal of Medicinal Chemistry, 68(4), pp. 4237–4258. doi: 10.1021/acs.jmedchem.4c01989.
• Pliatsika, D., Blatter, C. and Riedl, R. (2024) 'Targeted protein degradation : current molecular targets, localization, and strategies', Drug Discovery Today, 29(11), p. 104178. doi: 10.1016/j.drudis.2024.104178.
• Kalbermatter, D. et al. (2023) 'Structure and supramolecular organization of the canine distemper virus attachment glycoprotein', Proceedings of the National Academy of Sciences of the United States of America, 120(6), p. e2208866120. doi: 10.1073/pnas.2208866120.
• Zizzari, A. T. et al. (2021) 'New perspectives in oral peptide delivery', Drug Discovery Today, 26(4), pp. 1097–1105. doi: 10.1016/j.drudis.2021.01.020.

Oral conference contributions and abstracts

Rimle, L. et al. (2024) 'Molecular basis for leucinostatin A toxicity in mammals', in Biochimica et Biophysica Acta (BBA) - Bioenergetics. Elsevier. doi: 10.1016/j.bbabio.2024.149316.

Patents and patent applications

• Adams, Michael; Kemmler, Michael; Tobler, Andreas; Pliatsika, Dimanthi; Riedl, Rainer,

  2025.

  Compounds for treatment of cancer.

  Patent number WO2025172389 A1

  (2025-08-21)

  .

  Available from: https://worldwide.espacenet.com/patent/search?q=pn%3DWO2025172389A1

• Adams, Michael; Kemmler, Michael; Pliatsika, Dimanthi; Riedl, Rainer,

  2024.

  Topical treatment of skin cancer using oligopeptides.

  Patent number WO2024033418 A1

  (2024-02-15)

  .

  Available from: https://worldwide.espacenet.com/patent/search?q=pn%3DWO2024033418A1

• Adams, Michael; Kemmler, Michael; Riedl, Rainer; Pliatsika, Dimanthi; Imanidis, Georgios; Herzig, Susanne; Kaiser, Marcel; Mäser, Pascal,

  2022.

  Treatment of skin disorders.

  Patent number WO2022167656 A1

  (2022-08-11)

  .

  Available from: https://worldwide.espacenet.com/patent/search?q=pn%3DWO2022167656A1

go back